Quantcast
 
New book by Larry Connors Click here Improve your trading - See how
Quote
News
Trading News
Breaking News
Most Read
Stock News
Stock Alert
Market Analysis
Stock Index
All Trading News
PowerRatings
Stock Ratings
Upgrades
Downgrades


Markets Worldwide
Day Trading
Stock Trading
Stock Picking
Swing Trading
Forex Trading
Futures Trading
Emini Trading
Options Trading
Online Trading
Stock Market Analysis
Stock Rating
View More Topics >>
View Trading Glossary >>

OMRI

Law Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, Inc. -- OMRI - 12/03 - 01:46 PM ET

Omrix Biopharmaceuticals Closed Friday at Highest Level in Over Two Months - 11/24 - 08:15 AM ET

Omrix Biopharmaceuticals Closes At Highest Level In Over 2 Months - 11/21 - 04:22 PM ET

OMRI: To Present At Credit Suisse Healthcare Conference @ 11:00 ET [delayed] - 11/14 - 09:23 AM ET

OMRI: To Present At Rodman & Renshaw Investment Conference @ 14:25 ET [delayed] - 11/10 - 12:54 PM ET

OMRI: Q3 Earnings Call @ 16:30 ET Today [delayed] - 11/06 - 02:01 PM ET

Omrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare Conference - 11/06 - 01:47 PM ET

BRIEF-Omrix Biopharmaceuticals Q3 results - 11/06 - 07:09 AM ET

Omrix Biopharmaceuticals to Webcast Presentation at Rodman & Renshaw Annual Healthcare Conference - 11/04 - 08:00 AM ET

Omrix Biopharmaceuticals Reschedules its Third Quarter 2008 Financial Results and Conference Call to an Earlier Time on November 6, 2008 - 11/03 - 08:00 AM ET

Omrix to resume enrollment in US Phase II fibrin pad trial - 10/27 - 12:41 PM ET

BRIEF-Omrix Biopharma to resume patient enrollment for Fibrin trials - 10/24 - 03:33 PM ET

Omrix Biopharmaceuticals Announces Patient Enrollment Will Resume In Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding - 10/24 - 03:27 PM ET

Omrix Biopharmaceuticals Inc reports preliminary figures for third quarter 2008 - 10/21 - 08:27 AM ET

Omrix Biopharmaceuticals Announces Third Quarter 2008 Financial Results Date and Conference Call - 10/21 - 08:00 AM ET

BRIEF-Omrix provides preliminary Q3 results - 10/20 - 07:18 AM ET

OMRIX BIOPHARMACEUTICALS INC Q3 REVENUE ROSE 35 PCT TO $21.3 MLN - 10/20 - 07:15 AM ET

OMRIX BIOPHARMACEUTICALS INC REUTERS ESTIMATES Q3 REV VIEW $19.10 MLN - 10/20 - 07:15 AM ET

OMRIX BIOPHARMACEUTICALS INC SEES 2008 PRODUCT SALES OF $70-$72.0 MILLION - 10/20 - 07:15 AM ET

Omrix Biopharmaceuticals Provides Preliminary Third Quarter 2008 Results and Increases 2008 Product Sales Guidance - 10/20 - 07:12 AM ET

Page 1 of 6     1  2   3   4   5   >   >>|     Previous  |  Next

<< Back to Stock Index

 

Most Popular News
  1. XplosiveStocks.com: Freddie Mac (NYSE: FRE) today Hot Stock on the Move!
     
  2. What Happened to Apple? Asks Market Timer Frank Kollar
     
  3. XplosiveStocks.com: Ford Motor Company (NYSE: F) Hot Stock on the Move!
     
  4. National City deal worth $200M to executives
     
  5. FirstAlert[tm] 12/2: DOWn Again
     
    More News >>
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
Stocks
Options
Forex
E-mini/Futures
How to Trade
Tools
PowerRatings
Trading Contests
Premium Subscription Services
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback

All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.
© 2008 The Connors Group, Inc.